BioCentury | May 31, 2010
Finance

Performance Counts

...February 2010) by Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) $96.1 Platform: cell-based therapy Mepact mifamurtide [Ciba-Geigy; Jenner Biotherapies Inc.]...
BioCentury | Jun 4, 2007
Strategy

Rearview mirror

...the future of Junovan and fixing IDMI's cash situation. IDMI acquired Junovan in 2003 from Jenner Biotherapies Inc....
BioCentury | May 14, 2007
Regulation

A roll of the dice

...market would be too small to justify its R&D costs. Junovan was picked up by Jenner Biotherapies Inc....
BioCentury | Oct 6, 2003
Finance

Europe looks to follow-on

...I/II trials. Its MEPACT macrophage activator to treat pediatric osteosarcoma was acquired in April from Jenner Biotherapies Inc....
BioCentury | Aug 4, 2003
Strategy

Bellwether thinking

...employs 25 people, in California in June 2002. This year, IDM acquired cancer-related assets from Jenner Biotherapies Inc....
BioCentury | Apr 14, 2003
Company News

IDM SA, Jenner deal

...further develop the compound, which has Orphan Product designation. Immuno-Designed Molecules S.A. , Paris, France Jenner Biotherapies Inc....
BioCentury | Apr 14, 2003
Finance

Ebb & Flow

...is using its private equity to acquire cancer-related assets in a fire sale by U.S.-based Jenner Biotherapies...
BioCentury | Apr 9, 2003
Company News

Immuno-Designed, Jenner cancer deal

...Cellular immunotherapy and cancer company Immuno-Designed Molecules (Paris, France) acquired certain cancer-related assets from Jenner Biotherapies (Walworth...
BioCentury | Nov 12, 2001
Company News

Advanced Photonix Inc., Jenner deal

...1999 Phase II trial of Jenner’s prostate cancer vaccine. Advanced Photonix Inc. (API), Camarillo, Calif. Jenner Biotherapies Inc....
BioCentury | Oct 1, 2001
Company News

Advanced Photonix Inc., Jenner deal

...trial of its MEPACT macrophage activator to treat osteosarcoma. Advanced Photonix Inc. (API), Camarillo, Calif. Jenner Biotherapies Inc....
Items per page:
1 - 10 of 23
BioCentury | May 31, 2010
Finance

Performance Counts

...February 2010) by Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) $96.1 Platform: cell-based therapy Mepact mifamurtide [Ciba-Geigy; Jenner Biotherapies Inc.]...
BioCentury | Jun 4, 2007
Strategy

Rearview mirror

...the future of Junovan and fixing IDMI's cash situation. IDMI acquired Junovan in 2003 from Jenner Biotherapies Inc....
BioCentury | May 14, 2007
Regulation

A roll of the dice

...market would be too small to justify its R&D costs. Junovan was picked up by Jenner Biotherapies Inc....
BioCentury | Oct 6, 2003
Finance

Europe looks to follow-on

...I/II trials. Its MEPACT macrophage activator to treat pediatric osteosarcoma was acquired in April from Jenner Biotherapies Inc....
BioCentury | Aug 4, 2003
Strategy

Bellwether thinking

...employs 25 people, in California in June 2002. This year, IDM acquired cancer-related assets from Jenner Biotherapies Inc....
BioCentury | Apr 14, 2003
Company News

IDM SA, Jenner deal

...further develop the compound, which has Orphan Product designation. Immuno-Designed Molecules S.A. , Paris, France Jenner Biotherapies Inc....
BioCentury | Apr 14, 2003
Finance

Ebb & Flow

...is using its private equity to acquire cancer-related assets in a fire sale by U.S.-based Jenner Biotherapies...
BioCentury | Apr 9, 2003
Company News

Immuno-Designed, Jenner cancer deal

...Cellular immunotherapy and cancer company Immuno-Designed Molecules (Paris, France) acquired certain cancer-related assets from Jenner Biotherapies (Walworth...
BioCentury | Nov 12, 2001
Company News

Advanced Photonix Inc., Jenner deal

...1999 Phase II trial of Jenner’s prostate cancer vaccine. Advanced Photonix Inc. (API), Camarillo, Calif. Jenner Biotherapies Inc....
BioCentury | Oct 1, 2001
Company News

Advanced Photonix Inc., Jenner deal

...trial of its MEPACT macrophage activator to treat osteosarcoma. Advanced Photonix Inc. (API), Camarillo, Calif. Jenner Biotherapies Inc....
Items per page:
1 - 10 of 23